NISSAN CHEM IND/ADR (OTCMKTS:NNCHY) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of NISSAN CHEM IND/ADR (OTCMKTS:NNCHY) from a sell rating to a hold rating in a report issued on Thursday morning, Zacks.com reports.

According to Zacks, “Nissan Chemical Corporation is a chemical manufacturing company. It offers melamine, sulfuric acid, nitric acid and ammonia; fine chemicals, including special epoxy, flame retardant and disinfectant. Nissan Chemical Corporation, formerly known as Nissan Chemical Industries Ltd., is based in Tokyo, Japan. “

OTCMKTS NNCHY opened at $45.19 on Thursday. The company’s 50-day moving average price is $43.25. NISSAN CHEM IND/ADR has a twelve month low of $41.85 and a twelve month high of $54.81. The company has a quick ratio of 1.90, a current ratio of 3.10 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $6.73 billion, a P/E ratio of 25.39, a price-to-earnings-growth ratio of 2.26 and a beta of 0.53.

NISSAN CHEM IND/ADR (OTCMKTS:NNCHY) last released its quarterly earnings results on Wednesday, May 15th. The company reported $0.64 earnings per share for the quarter. The firm had revenue of $572.13 million for the quarter. Analysts expect that NISSAN CHEM IND/ADR will post 2 earnings per share for the current year.

NISSAN CHEM IND/ADR Company Profile

Nissan Chemical Corporation engages in chemicals, performance materials, agricultural chemicals, pharmaceuticals, and advanced materials and planning businesses in Japan and internationally. Its chemical products include MELAMINE, an adhesive agent; high purity chemicals; AdBlue, a urea solution; FINEOXOCOL, a saturated fatty alcohol and acid; ammonia, sulfuric, and nitric acid; TEPIC, an epoxy compound; Melamine Cyanurate, a flame retardant; Nissan Reishi, a health food; phenylphosphonic acid, a surface modifier; HI-LITE, a chlorinated isocyanulate; and OPTBEADS, a melamine-formaldehyde resin and silica.

Recommended Story: The benefits and drawbacks of dollar cost averaging

Get a free copy of the Zacks research report on NISSAN CHEM IND/ADR (NNCHY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for NISSAN CHEM IND/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NISSAN CHEM IND/ADR and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit